Dimethyl Sulfoxide USP, PhEur in Approved Pharmaceutical Products and Medical Devices - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Dimethyl Sulfoxide USP, PhEur in Approved Pharmaceutical Products and Medical Devices
The authors survey the approved applications of dimethyl sulfoxide USP, PhEur across the healthcare industry and consider the suitability of DMSO from a regulatory and formulation compatibility standpoint.


Pharmaceutical Technology


22. P.W. Davis "An Incipient 'Wonder Drug' Movement: DMSO and the Food and Drug Administration," Social Problems 32 (32), 197–212 (1984).

23. L. Murdoch "Dimethyl Sulfoxide—An Overview," Canadian Journal of Hospital Pharmacy, 35 (3), 79–85 (1982).

24. A.M Kligman, "Topical Pharmacology and Toxicology of Dimethyl Sulfoxide (DMSO) Part 1," J. Amer. Med. Assoc. 193, 140–148 (1965)

25. A.M Kligman "Topical Pharmacology and Toxicology of Dimethyl Sulfoxide (DMSO) Part 2," J. Amer. Med. Assoc. 193, 151–156 (1965)

26. R.D. Brobyn, "The Human Toxicology of Dimethyl Sulfoxide," J. Amer. Med. Assoc. 243, 497–506 (1975).

27. "The Riddle of DMSO," Narr. Mike Wallace, Prod. Marion Goldin CBS Television Network, March 23, 1980.

28. M.D. Anderson Cancer Center "Herbal/Plant Therapies: DMSO (Dimethyl Sulfoxide)" http://www.mdanderson.org/departments/cimer/display.cfm?id=8e9bcb72-f0a0-11d4-810300508b603a14&method=displayfull&pn=6eb86a59-ebd9-11d4-810100508b603a14 (Sept. 2007), accessed Mar. 14, 2008.

29. B.H Ali, "Dimethyl Sulfoxide: Recent Pharmacological and Toxicological Research," Vet. Human Toxicol. 43 (4) 228–231 (2001).

30. US EPA, "High Production Volume Challenge: Robust Summaries and Test Plans: Dimethyl Sulfoxide" http://www.epa.gov/chemrtk/pubssummaries/dimthslf/c14721tc.htm (Oct. 16, 2007).

31. T.J. Franz, P.A. Lehman, and M.K. Kagy, "Dimethylsulfoxide," in Percutaneous Penetration Enhancers, E.W. Smith and H.I. Maibach, Eds. (CRC Press, Boca Raton, FL, 1st ed, 1995), pp. 116–127.

32. C. Ursin et al., "Permeability of Commercial Solvents Through Living Human Skin," Am. Ind. Hyg. Assoc. J. 56, 651–660 (1995).

33. Chemical Effect Information Center, Problem Definition Study of Dimethyl Sulfoxide (DMSO) and Interactive Health Effects with Other Chemicals, Final Report (Oak Ridge National Laboratory, Oak Ridge, TN, 1984), p. 53.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here